Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.7M Buy
109,988
+877
+0.8% +$99.7K ﹤0.01% 1117
2025
Q4
$11.6M Sell
109,111
-219
-0.2% -$22.1K ﹤0.01% 1062
2025
Q3
$10.2M Sell
109,330
-108,166
-50% -$10.1M ﹤0.01% 1061
2025
Q2
$18.9M Buy
217,496
+74,252
+52% +$6.21M ﹤0.01% 1072
2025
Q1
$11M Buy
143,244
+14,723
+11% +$1.35M ﹤0.01% 1181
2024
Q4
$12.4M Buy
128,521
+17,958
+16% +$1.81M ﹤0.01% 1145
2024
Q3
$10.5M Sell
110,563
-333
-0.3% -$29.1K ﹤0.01% 1195
2024
Q2
$9.25M Buy
110,896
+48,980
+79% +$4.08M ﹤0.01% 1169
2024
Q1
$5.32M Buy
61,916
+3,163
+5% +$257K ﹤0.01% 1229
2023
Q4
$4.86M Buy
58,753
+1,337
+2% +$98.1K ﹤0.01% 1255
2023
Q3
$4.13M Sell
57,416
-996
-2% -$75.6K ﹤0.01% 1295
2023
Q2
$3.69M Hold
58,412
﹤0.01% 1371
2023
Q1
$3.69M Buy
58,412
+7,605
+15% +$446K ﹤0.01% 1371
2022
Q4
$2.76M Sell
50,807
-399
-0.8% -$23.7K ﹤0.01% 1394
2022
Q3
$2.93M Sell
51,206
-10,213
-17% -$566K ﹤0.01% 1403
2022
Q2
$2.85M Sell
61,419
-507
-0.8% -$26.6K ﹤0.01% 1460
2022
Q1
$3.55M Buy
61,926
+7,411
+14% +$382K ﹤0.01% 1505
2021
Q4
$2.87M Sell
54,515
-2,163
-4% -$116K ﹤0.01% 1696
2021
Q3
$2.84M Hold
56,678
﹤0.01% 1674
2021
Q2
$3.33M Buy
56,678
+2,543
+5% +$157K ﹤0.01% 1595
2021
Q1
$3.52M Sell
54,135
-1,218
-2% -$74.8K ﹤0.01% 1505
2020
Q4
$3.04M Sell
55,353
-821
-1% -$41.9K ﹤0.01% 1515
2020
Q3
$2.48M Buy
56,174
+2,526
+5% +$111K ﹤0.01% 1461
2020
Q2
$2.26M Buy
53,648
+2,759
+5% +$106K ﹤0.01% 1469
2020
Q1
$2.02M Sell
50,889
-1,446
-3% -$61.1K ﹤0.01% 1402
2019
Q4
$2.33M Buy
52,335
+12,560
+32% +$483K ﹤0.01% 1528
2019
Q3
$1.36M Sell
39,775
-2,332
-6% -$80.7K ﹤0.01% 1799
2019
Q2
$1.58M Sell
42,107
-22,392
-35% -$766K ﹤0.01% 1700
2019
Q1
$1.97M Buy
64,499
+12,776
+25% +$390K ﹤0.01% 1527
2018
Q4
$1.43M Buy
+51,723
New +$1.42M ﹤0.01% 1578

Other funds holding ACA

UBS AM's ACA Position: Q1 2026 in Review

UBS AM increased its Arcosa (ACA) stake by 0.8% in Q1 2026, buying an estimated $99.7K and bringing the position to 109,988 shares worth $11.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

UBS AM first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. The position peaked at $18.9M in Q2 2025. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • UBS AM held 109,988 shares of Arcosa worth $11.7M as of Q1 2026.
  • UBS AM bought 877 Arcosa shares in Q1 2026, an estimated $99.7K.
  • Arcosa made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #1117 holding.
  • UBS AM first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
  • UBS AM's Arcosa position peaked at $18.9M in Q2 2025.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.